new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Sloan kettering Institute For Cancer Research
Sloan kettering Institute For Cancer Research In The City Of New York
  

Sloan kettering Institute For Cancer Research patents

Recent patent applications related to Sloan kettering Institute For Cancer Research. Sloan kettering Institute For Cancer Research is listed as an Agent/Assignee. Note: Sloan kettering Institute For Cancer Research may have other listings under different names/spellings. We're not affiliated with Sloan kettering Institute For Cancer Research, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Sloan kettering Institute For Cancer Research-related inventors




Date Sloan kettering Institute For Cancer Research patents (updated weekly) - BOOKMARK this page
05/11/17Uses of monoclonal antibody 8h9
05/04/17Cdc7 kinase inhibitors and uses thereof
04/27/17One-step labeling of antibodies to high specific activity with actinium-225
03/23/17Synthesis of thiohydantoins
03/09/17Novel molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase
02/09/17Treatment of tumors expressing mutant p53
02/02/17Antibodies to human b7x for treatment of metastatic cancer
01/19/17Sgk1 inhibitors for treatment of prostate cancer
01/05/17Crystalline forms of an androgen receptor modulator
11/17/16Small-molecule hsp90 inhibitors
10/27/16Purine derivatives useful as hsp90 inhibitors
10/06/16Glucocorticoid inhibitors for treatment of prostate cancer
09/22/16Methods and compositions for inducing regulatory t-cell generation
09/15/16Hematopoietic recovery from radiation injury
09/15/16Hsp90 inhibitors
09/01/16Polyvalent conjugate vaccine for cancer
08/18/16Methods and compositions for regulatory t-cell ablation
08/11/16Methods and compositions for imaging disorders using polyspecific agents
08/04/16Migrastatins and uses thereof
07/28/16Granulocyte macrophage colony-stimulating factor compositions
06/16/16Therapy-enhancing glucan
04/21/16V3 immunogens
04/14/16Articles and methods for preventing and treating dermatologic adverse events
03/24/16Clinical multimodality-tools for pre-and intraoperative insulinoma diagnostics
03/03/16Cdc7 kinase inhibitors and uses thereof
02/25/16Methyltransferase inhibitors for treating cancers
01/07/16Wide field raman imaging apparatus and associated methods
11/19/15Multimodal particles, methods and uses thereof
11/05/15Compositions and methods for the treatment of cancers associated with a deficiency in the mre11/rad50/nbs1 dna damage repair complex
10/08/15Synthetic env proteins
10/01/15Methods for treating or preventing cancer and neurodegenerative diseases
10/01/15Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing
09/17/15Particles, methods and uses thereof
07/09/15Synthesis of thiohydantoins
06/25/15Synthesis of epothilones, intermediates thereto and analogues thereof
05/14/15Coumarin-based compounds for the treatment of alzheimer's disease and cancer
04/30/15Inhibition of colony stimulating factor-1 receptor signaling for the treatment of brain cancer
04/23/15Hdc-sign binding peptides
03/26/15Compositions and methods for treating cancer using interferon and mapk pathway inhibitor
03/26/15Peptide-conjugated oligonucleotide therapeutic and making and using same
03/19/15Topical corneal analgesia using neurotensin receptor agonists and synergistic neurotensin combinations without delaying wound healing
03/05/15S100a8/a9 as a diagnostic marker and a therapeutic target
02/05/15Prediction of responsiveness to treatment with immunomodulatory therapeutics and monitoring abscopal effects during such treatment
12/25/14Treatment of neurodegenerative diseases through inhibition of hsp90
11/27/14Raman based ablation/resection systems and methods
10/23/14Hsp90 combination therapy
10/02/14Uses of labeled hsp90 inhibitors
09/25/14Novel molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1
09/18/14Novel glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof
09/04/14Multimodal silica-based nanoparticles
08/28/14Uses of labeled hsp90 inhibitors
08/14/14Parathyroid hormone analogs, compositions and uses thereof
06/12/14Uses of monoclonal antibody 8h9
04/24/14Epigenomic markers of cancer metastasis
03/27/14Hsp90 inhibitors
02/13/14Hsp90 inhibitors
02/06/14Polyvalent conjugate vaccine for cancer
01/30/14Selective hdac inhibitors
01/23/14Migrastatins and uses thereof
01/09/14Migrastatin analogs and uses thereof
12/05/13Homogenous and fully glycosylated human erythropoietin
12/05/13Rxrg modulators for the treatment of cancer
08/29/13Synthesis of thiohydantoins
07/18/13Therapy-enhancing glucan
06/20/13Methods for treating or preventing cancer and neurodegenerative diseases
Patent Packs
04/18/13Multivalent glycopeptide constructs and uses thereof
02/28/13Treatment of t-cell lymphoma using 10-propargyl-10-deazaaminopterin
02/14/13Fluorescent silica-based nanoparticles
02/07/13Cdc7 kinase inhibitors and uses thereof
02/07/13Compounds for the treatment of ocular cancer
01/10/13Triterpene saponins, methods of synthesis, and uses thereof
01/10/13Metalloproteinase oligopeptides and their therapeutic use
01/10/13Polyepitope constructs and methods for their preparation and use
11/22/12Method of predicting and reducing risk of metastasis of breast cancer to lung
11/01/12Anti ganglioside gd3 antibodies and uses thereof
10/18/12Polyvalent conjugate vaccine for cancer
09/13/12Multi-source radiation interwoven radiotherapy and imaging
08/16/12Hsp90 inhibitors
03/22/12Benzofuran-4,5-diones as selective peptide deformylase inhibitors
12/22/11Cardenolides for the treatment of ocular cancer
Patent Packs
12/22/11Methods of detection of cancer using peptide profiles
12/22/11Small-molecule hsp90 inhibitors
12/15/11Coumarin-based compounds for the treatment of alzheimer's disease and cancer
12/08/1118f-labelled three-and four-carbon acids for pet imaging
11/17/11Migrastatin analogs and uses thereof
11/03/11Microscope slide holder and use
10/27/11Synthesis of epothilones, intermediates thereto, analogues and uses thereof
10/20/11Allogeneic vaccine and methods to synthesize same
09/22/11Glycopeptide constructs and uses thereof
08/11/11Therapy-enhancing glucan
05/26/11Method of treatment for cancers associated with elevated her2 levels
05/26/11Treatment of neurodegenerative diseases and cancer of the brain using histone deacetylase inhibitors
05/12/11Methods for assessing cancer for increased sensitivity to 10-propargyl-10-deazaaminopterin
05/05/11Small-molecule hsp90 inhibitors
04/21/11Administration of exogenous mi/sirna
03/24/11Cephalotaxus esters, methods of synthesis, and uses thereof
03/03/11Gene signatures for the prognosis of cancer
01/06/11Peptide-conjugated oligonucleotide therapeutic and making and using same
12/30/10Gpr125 as a marker for stem and progenitor cells and methods use thereof
12/09/10Uses of monoclonal antibody 8h9
11/11/10Uses of monoclonal antibody 8h9
10/28/10Therapy-enhancing glucan
09/09/10Method for preparation of single chain antibodies
08/26/10Therapy-enhancing glucan
08/19/10Pyridazinones and furan-containing compounds
07/01/10Methods to treat cancer with 10-propargyl-10-deazaaminopterin and methods for assessing cancer for increased sensitivity to 10-propargyl-10-deazaaminopterin
06/10/10Uses of monoclonal antibody 8h9
05/13/10Treatment of t-cell lymphoma using 10-propargyl-10-deazaaminopterin
04/15/10Methods and compositions for promoting survival & proliferation of endothelial cells & stimulating angiogenesis
03/18/10Method and compositions for stimulation of an immune response to gp100 using a xenogeneic gp100 antigen
Social Network Patent Pack
03/18/10Method and compositions for stimulation of an immune response to psma using a xenogeneic psma antigen
03/18/10Method and compositions for stimulation of an immune response to trp2 using a xenogeneic trp2 antigen
02/04/10Metastasis promoting genes and proteins
01/21/10Identification and isolation of adult stem cells and related methods of use
01/14/10Anti ganglioside gd3 antibodies and uses thereof
11/05/09Mutant viruses
03/12/09Method for molecular cloning and polynucleotide synthesis using vaccinia dna topoisomerase
06/30/11Allogeneic vaccine and methods to synthesize same







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Sloan kettering Institute For Cancer Research in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Sloan kettering Institute For Cancer Research with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';